Preventing hearing loss from cisplatin in head and neck cancer
Part of Ear, nose & throat clinical trials.
This trial tests whether a gel placed in the ear can protect against hearing loss caused by high-dose cisplatin chemotherapy. It is for people with head and neck cancer who are scheduled to receive a certain amount of cisplatin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head or neck cancer that can be treated with high-dose cisplatin (at least 200 mg/m² total).
- You are able to give written consent and are 18 or older.
- Your hearing before treatment is similar in both ears and not worse than a mild loss.
- You are not getting more than 30 Gy of radiation to the inner ear area.
- You do not have any ear problems that would prevent the gel from reaching the round window.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called sodium thiosulfate can protect your hearing from the side effects of cisplatin chemotherapy. It is for people with newly diagnosed cancer who are about to receive cisplatin for the first time.
This Phase 2 trial tests whether sodium thiosulfate and mannitol can reduce hearing damage (ototoxicity) in adults receiving cisplatin chemotherapy. It may help protect hearing while you get cancer treatment.
This Phase 2 trial tests whether a cholesterol medicine called atorvastatin can protect hearing in people with head and neck cancer receiving cisplatin plus radiation. If it works, it may reduce the chance or severity of treatment-related hearing damage.
This program provides access to sodium thiosulfate (STS) for children with hepatoblastoma who are receiving cisplatin chemotherapy. The drug may help protect the kidneys from cisplatin's side effects, and the goal is to give patients a chance to benefit from this treatment.
This trial tests if taking N-acetylcysteine (NAC) can help prevent hearing loss caused by high-dose cisplatin chemotherapy. If you're getting cisplatin and are between 18 and 70, you may be able to join.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares patients who get cisplatin with those who only get radiation, to understand and possibly reduce these side effects.
Hear when a new Cisplatin-related Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.